<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37626735</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Role of Endothelium in Cardiovascular Sequelae of Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2239</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11082239</ELocationID><Abstract><AbstractText>The global action against coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 infection, shed light on endothelial dysfunction. Although SARS-CoV-2 primarily affects the pulmonary system, multiple studies have documented pan-vascular involvement in COVID-19. The virus is able to penetrate the endothelial barrier, damaging it directly or indirectly and causing endotheliitis and multi-organ injury. Several mechanisms cooperate to development of endothelial dysfunction, including endothelial cell injury and pyroptosis, hyperinflammation and cytokine storm syndrome, oxidative stress and reduced nitric oxide bioavailability, glycocalyx disruption, hypercoagulability, and thrombosis. After acute-phase infection, some patients reported signs and symptoms of a systemic disorder known as long COVID, in which a broad range of cardiovascular (CV) disorders emerged. To date, the exact pathophysiology of long COVID remains unclear: in addition to the persistence of acute-phase infection mechanisms, specific pathways of CV damage have been postulated, such as persistent viral reservoirs in the heart or an autoimmune response to cardiac antigens through molecular mimicry. The aim of this review is to provide an overview of the main molecular patterns of enduring endothelial activation following SARS-CoV-2 infection and to offer the latest summary of CV complications in long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3614-7314</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaccone</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5285-859X</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Internal and Sub-Intensive Medicine, Azienda Ospedaliero-Universitaria delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falsetti</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3411-2388</Identifier><AffiliationInfo><Affiliation>Clinica Medica, Department of Clinical and Molecular Sciences, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggieri</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danese</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miro</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Giorgio</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nesci</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alessandro</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moroncini</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinica Medica, Department of Clinical and Molecular Sciences, Universit&#xe0; Politecnica delle Marche, 60126 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoliquido</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">endothelium</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">post-acute sequelae SARS-CoV-2 infection (PASC)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37626735</ArticleId><ArticleId IdType="pmc">PMC10452509</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11082239</ArticleId><ArticleId IdType="pii">biomedicines11082239</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzik T.J., Mohiddin S.A., Dimarco A., Patel V., Savvatis K., Marelli-Berg F.M., Madhur M.S., Tomaszewski M., Maffia P., D&#x2032;Acquisto F., et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020;116:1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Six I., Guillaume N., Jacob V., Mentaverri R., Kamel S., Boullier A., Slama M. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19. Int. J. Mol. Sci. 2022;23:6196. doi: 10.3390/ijms23116196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23116196</ArticleId><ArticleId IdType="pmc">PMC9181280</ArticleId><ArticleId IdType="pubmed">35682871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer S., Steinmetz M., Asdonk T., Motz I., Coch C., Hartmann E., Barchet W., Wassmann S., Hartmann G., Nickenig G. Activation of endothelial toll-like receptor 3 impairs endothelial function. Circ. Res. 2011;108:1358&#x2013;1366. doi: 10.1161/CIRCRESAHA.111.243246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.111.243246</ArticleId><ArticleId IdType="pubmed">21493895</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans P.C., Rainger G.E., Mason J.C., Guzik T.J., Osto E., Stamataki Z., Neil D., Hoefer I.E., Fragiadaki M., Waltenberger J., et al. Endothelial dysfunction in COVID-19: A position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc. Res. 2020;116:2177&#x2013;2184. doi: 10.1093/cvr/cvaa230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa230</ArticleId><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE); London, UK: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagova O., Varionchik N., Zaidenov V., Savina P., Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur. J. Immunol. 2021;51:893&#x2013;902. doi: 10.1002/eji.202048930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048930</ArticleId><ArticleId IdType="pubmed">33368288</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A., Kontorovich A.R., Fuster V., Dec G.W. Viral myocarditis&#x2014;Diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015;12:670&#x2013;680. doi: 10.1038/nrcardio.2015.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladka M.M., Maack C. The endothelium as Achilles&#x2032; heel in COVID-19 patients. Cardiovasc. Res. 2020;116:e195&#x2013;e197. doi: 10.1093/cvr/cvaa327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa327</ArticleId><ArticleId IdType="pmc">PMC7717148</ArticleId><ArticleId IdType="pubmed">33167001</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C., Mulvey J.J., Berlin D., Nuovo G., Salvatore S., Harp J., Baxter-Stolzfus A., Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl. Res. 2020;220:1&#x2013;13. doi: 10.1016/j.trsl.2020.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 2003;23:168&#x2013;175. doi: 10.1161/01.ATV.0000051384.43104.FC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000051384.43104.FC</ArticleId><ArticleId IdType="pubmed">12588755</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori Y., Hattori K., Machida T., Matsuda N. Vascular endotheliitis associated with infections: Its pathogenetic role and therapeutic implication. Biochem. Pharmacol. 2022;197:114909. doi: 10.1016/j.bcp.2022.114909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2022.114909</ArticleId><ArticleId IdType="pmc">PMC8743392</ArticleId><ArticleId IdType="pubmed">35021044</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.W., Ilyas I., Weng J.P. Endothelial dysfunction in COVID-19: An overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol. Sin. 2023;44:695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A., Diz D.I., Gallagher P.E. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605&#x2013;2610. doi: 10.1161/CIRCULATIONAHA.104.510461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang Y., Luo W., Huang L., Xiao J., Li F., Qin S., Song X., Wu Y., Zeng Q., et al. A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells. Int. J. Med. Sci. 2020;17:1522&#x2013;1531. doi: 10.7150/ijms.46695.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.46695</ArticleId><ArticleId IdType="pmc">PMC7359402</ArticleId><ArticleId IdType="pubmed">32669955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M., Wysocki J., Naaz P., Salabat M.R., LaPointe M.S., Batlle D. Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: A renoprotective combination? Hypertension. 2004;43:1120&#x2013;1125. doi: 10.1161/01.HYP.0000126192.27644.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000126192.27644.76</ArticleId><ArticleId IdType="pubmed">15078862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., M&#xe9;ar L., Edvinsson &#xc5;., Micke P., Uhl&#xe9;n M., Lindskog C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16:e9610. doi: 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell. Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H., Stein D.A., Hardes K., Eickmann M., Dolnik O., et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci. Alliance. 2020;3:e202000786. doi: 10.26508/lsa.202000786.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000786</ArticleId><ArticleId IdType="pmc">PMC7383062</ArticleId><ArticleId IdType="pubmed">32703818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipeto D., Palmeira J.D.F., Arga&#xf1;araz G.A., Arga&#xf1;araz E.R. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19. Front. Immunol. 2020;7:576745. doi: 10.3389/fimmu.2020.576745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.576745</ArticleId><ArticleId IdType="pmc">PMC7575774</ArticleId><ArticleId IdType="pubmed">33117379</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P.K., Griendling K.K. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell. Physiol. 2007;292:C82&#x2013;C97. doi: 10.1152/ajpcell.00287.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00287.2006</ArticleId><ArticleId IdType="pubmed">16870827</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.A.S., Sampaio W.O., Alzamora A.C., Motta-Santos D., Alenina N., Bader M., Campagnole-Santos M.J. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7) Physiol. Rev. 2018;98:505&#x2013;553. doi: 10.1152/physrev.00023.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00023.2016</ArticleId><ArticleId IdType="pmc">PMC7203574</ArticleId><ArticleId IdType="pubmed">29351514</ArticleId></ArticleIdList></Reference><Reference><Citation>De Queiroz T.M., Lakkappa N., Lazartigues E. ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension. Front. Pharmacol. 2020;29:1154. doi: 10.3389/fphar.2020.01154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01154</ArticleId><ArticleId IdType="pmc">PMC7403492</ArticleId><ArticleId IdType="pubmed">32848763</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia P., Cavallini C., Spanevello A., Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur. J. Intern. Med. 2020;76:14&#x2013;20. doi: 10.1016/j.ejim.2020.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.04.037</ArticleId><ArticleId IdType="pmc">PMC7167588</ArticleId><ArticleId IdType="pubmed">32336612</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G., Pinney S.P., Lala A., Reddy V.Y., Johnston-Cox H.A., Mechanick J.I., Halperin J.L., Fuster V. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar. J. Am. Coll. Cardiol. 2020;76:2011&#x2013;2023. doi: 10.1016/j.jacc.2020.08.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.059</ArticleId><ArticleId IdType="pmc">PMC7572122</ArticleId><ArticleId IdType="pubmed">33092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues T.S., de S&#xe1; K.S.G., Ishimoto A.Y., Becerra A., Oliveira S., Almeida L., Gon&#xe7;alves A.V., Perucello D.B., Andrade W.A., Castro R., et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 2021;218:e20201707. doi: 10.1084/jem.20201707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N., Di B., Xu L.L. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev. 2021;61:2&#x2013;15. doi: 10.1016/j.cytogfr.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8233448</ArticleId><ArticleId IdType="pubmed">34183243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley N., Jeltema D., Duan Y., He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci. 2019;20:3328. doi: 10.3390/ijms20133328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133328</ArticleId><ArticleId IdType="pmc">PMC6651423</ArticleId><ArticleId IdType="pubmed">31284572</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen I.Y., Moriyama M., Chang M.F., Ichinohe T. Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome. Front. Microbiol. 2019;10:50. doi: 10.3389/fmicb.2019.00050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00050</ArticleId><ArticleId IdType="pmc">PMC6361828</ArticleId><ArticleId IdType="pubmed">30761102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E., Qu R., Junqueira C., Kaffe E., Mirza H., Zhao J., Brewer J.R., Han A., Steach H.R., Israelow B., et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022;606:585&#x2013;593. doi: 10.1038/s41586-022-04802-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04802-1</ArticleId><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak M.Z., Bujko K., Ciechanowicz A., Sielatycka K., Cymer M., Marlicz W., Kucia M. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome. Stem Cell Rev. Rep. 2021;17:266&#x2013;277. doi: 10.1007/s12015-020-10010-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10010-z</ArticleId><ArticleId IdType="pmc">PMC7370872</ArticleId><ArticleId IdType="pubmed">32691370</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., Pan M., Zheng B., Chen Y., Li W., Yang Q., Zheng Z., Sun N., Zhang Y., Li X. Autophagy Attenuates Angiotensin II-Induced Pulmonary Fibrosis by Inhibiting Redox Imbalance-Mediated NOD-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation. Antioxid. Redox Signal. 2019;30:520&#x2013;541. doi: 10.1089/ars.2017.7261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7261</ArticleId><ArticleId IdType="pubmed">29486589</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J., Jia Y., et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat. Commun. 2021;12:4664. doi: 10.1038/s41467-021-25015-6. Erratum in Nat. Commun. 2021, 12, 5306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25015-6</ArticleId><ArticleId IdType="pmc">PMC8329225</ArticleId><ArticleId IdType="pubmed">34341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Torres J.L., Verdi&#xe1;-B&#xe1;guena C., Jimenez-Guarde&#xf1;o J.M., Regla-Nava J.A., Casta&#xf1;o-Rodriguez C., Fernandez-Delgado R., Torres J., Aguilella V.M., Enjuanes L. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology. 2015;485:330&#x2013;339. doi: 10.1016/j.virol.2015.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.08.010</ArticleId><ArticleId IdType="pmc">PMC4619128</ArticleId><ArticleId IdType="pubmed">26331680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A.C., Soares V.C., de Azevedo-Quintanilha I.G., Dias S.D.S.G., Fintelman-Rodrigues N., Sacramento C.Q., Mattos M., de Freitas C.S., Temerozo J.R., Teixeira L., et al. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell. Death Discov. 2021;7:43. doi: 10.1038/s41420-021-00428-w. Erratum in Cell. Death Discov. 2021, 7, 116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00428-w</ArticleId><ArticleId IdType="pmc">PMC7919254</ArticleId><ArticleId IdType="pubmed">33649297</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Xie X., Tu Z., Fu J., Xu D., Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target Ther. 2021;6:255. doi: 10.1038/s41392-021-00679-0. Erratum in Signal Transduct Target Ther. 2021, 6, 326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00679-0</ArticleId><ArticleId IdType="pmc">PMC8261820</ArticleId><ArticleId IdType="pubmed">34234112</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S.M., Hejazi M.S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., Farahzadi R., Ghasemnejad T. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 2022;19:92. doi: 10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8:420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X. Erratum in Lancet Respir. Med. 2020, 8, E26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Fan J.G. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease. J. Clin. Transl. Hepatol. 2020;8:13&#x2013;17. doi: 10.14218/JCTH.2020.00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/JCTH.2020.00019</ArticleId><ArticleId IdType="pmc">PMC7132021</ArticleId><ArticleId IdType="pubmed">32274341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya G., Kaya A., Saurat J.H. Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature. Dermatopathology. 2020;7:3&#x2013;16. doi: 10.3390/dermatopathology7010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/dermatopathology7010002</ArticleId><ArticleId IdType="pmc">PMC7583593</ArticleId><ArticleId IdType="pubmed">32608380</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5. Erratum in Lancet 2020, 395, 496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021;93:250&#x2013;256. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhl L., Pink I., K&#xfc;hne J.F., Beushausen K., Keil J., Christoph S., Sauer A., Boblitz L., Schmidt J., David S., et al. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal Transduct. Target Ther. 2021;6:418. doi: 10.1038/s41392-021-00819-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00819-6</ArticleId><ArticleId IdType="pmc">PMC8661333</ArticleId><ArticleId IdType="pubmed">34893580</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath I., Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23:1121&#x2013;1131. doi: 10.1161/01.HYP.23.6.1121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.23.6.1121</ArticleId><ArticleId IdType="pubmed">7515853</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rstermann U., M&#xfc;nzel T. Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation. 2006;113:1708&#x2013;1714. doi: 10.1161/CIRCULATIONAHA.105.602532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.602532</ArticleId><ArticleId IdType="pubmed">16585403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubes P., Kanwar S., Niu X., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 1993;7:1293&#x2013;1299. doi: 10.1096/fasebj.7.13.8405815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.7.13.8405815</ArticleId><ArticleId IdType="pubmed">8405815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurose I., Wolf R., Grisham M.B., Aw T.Y., Specian R.D., Granger D.N. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ. Res. 1995;76:30&#x2013;39. doi: 10.1161/01.RES.76.1.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.76.1.30</ArticleId><ArticleId IdType="pubmed">7528112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsihlis N.D., Oustwani C.S., Vavra A.K., Jiang Q., Keefer L.K., Kibbe M.R. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10. Cell Biochem. Biophys. 2011;60:89&#x2013;97. doi: 10.1007/s12013-011-9179-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-011-9179-3</ArticleId><ArticleId IdType="pmc">PMC6959532</ArticleId><ArticleId IdType="pubmed">21448667</ArticleId></ArticleIdList></Reference><Reference><Citation>Didion S.P. Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature. Int. J. Mol. Sci. 2017;18:2563. doi: 10.3390/ijms18122563.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18122563</ArticleId><ArticleId IdType="pmc">PMC5751166</ArticleId><ArticleId IdType="pubmed">29186034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvietys P.R., Granger D.N. Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic. Biol. Med. 2012;52:556&#x2013;592. doi: 10.1016/j.freeradbiomed.2011.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.11.002</ArticleId><ArticleId IdType="pmc">PMC3348846</ArticleId><ArticleId IdType="pubmed">22154653</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S., Park S. Role of vascular smooth muscle cell in the inflammation of atherosclerosis. BMB Rep. 2014;47:1&#x2013;7. doi: 10.5483/BMBRep.2014.47.1.285. Erratum in BMB Rep. 2016, 49, 34.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2014.47.1.285</ArticleId><ArticleId IdType="pmc">PMC4163848</ArticleId><ArticleId IdType="pubmed">24388105</ArticleId></ArticleIdList></Reference><Reference><Citation>Incalza M.A., D&#x2032;Oria R., Natalicchio A., Perrini S., Laviola L., Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul. Pharmacol. 2018;100:1&#x2013;19. doi: 10.1016/j.vph.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2017.05.005</ArticleId><ArticleId IdType="pubmed">28579545</ArticleId></ArticleIdList></Reference><Reference><Citation>Staiculescu M.C., Foote C., Meininger G.A., Martinez-Lemus L.A. The role of reactive oxygen species in microvascular remodeling. Int. J. Mol. Sci. 2014;15:23792&#x2013;23835. doi: 10.3390/ijms151223792.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms151223792</ArticleId><ArticleId IdType="pmc">PMC4284792</ArticleId><ArticleId IdType="pubmed">25535075</ArticleId></ArticleIdList></Reference><Reference><Citation>Akerstr&#xf6;m S., Mousavi-Jazi M., Klingstr&#xf6;m J., Leijon M., Lundkvist A., Mirazimi A. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J. Virol. 2005;79:1966&#x2013;1969. doi: 10.1128/JVI.79.3.1966-1969.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.3.1966-1969.2005</ArticleId><ArticleId IdType="pmc">PMC544093</ArticleId><ArticleId IdType="pubmed">15650225</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S.J. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. Microbes Infect. 2020;22:149&#x2013;150. doi: 10.1016/j.micinf.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7229726</ArticleId><ArticleId IdType="pubmed">32425647</ArticleId></ArticleIdList></Reference><Reference><Citation>Akwii R.G., Sajib M.S., Zahra F.T., Mikelis C.M. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology. Cells. 2019;8:471. doi: 10.3390/cells8050471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8050471</ArticleId><ArticleId IdType="pmc">PMC6562915</ArticleId><ArticleId IdType="pubmed">31108880</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F., Oliva A., Cangemi R., Ceccarelli G., Pignatelli P., Carnevale R., Cammisotto V., Lichtner M., Alessandri F., De Angelis M., et al. Nox2 activation in Covid-19. Redox Biol. 2020;36:101655. doi: 10.1016/j.redox.2020.101655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101655</ArticleId><ArticleId IdType="pmc">PMC7381406</ArticleId><ArticleId IdType="pubmed">32738789</ArticleId></ArticleIdList></Reference><Reference><Citation>Goonewardena S.N., Grushko O.G., Wells J., Herty L., Rosenson R.S., Haus J.M., Hummel S.L. Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients. Cardiovasc. Drugs Ther. 2023;37:307&#x2013;313. doi: 10.1007/s10557-021-07288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-021-07288-7</ArticleId><ArticleId IdType="pmc">PMC8600103</ArticleId><ArticleId IdType="pubmed">34792686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger-Genge A., Blocki A., Franke R.P., Jung F. Vascular Endothelial Cell Biology: An Update. Int. J. Mol. Sci. 2019;20:4411. doi: 10.3390/ijms20184411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184411</ArticleId><ArticleId IdType="pmc">PMC6769656</ArticleId><ArticleId IdType="pubmed">31500313</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldecoa C., Llau J.V., Nuvials X., Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: A review. Ann. Intensive Care. 2020;10:85. doi: 10.1186/s13613-020-00697-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00697-1</ArticleId><ArticleId IdType="pmc">PMC7310051</ArticleId><ArticleId IdType="pubmed">32572647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogn&#xe9; S., Flamion B. Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding. Am. J. Pathol. 2020;190:768&#x2013;780. doi: 10.1016/j.ajpath.2019.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2019.11.016</ArticleId><ArticleId IdType="pubmed">32035885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipowsky H.H. Role of the Glycocalyx as a Barrier to Leukocyte-Endothelium Adhesion. Adv. Exp. Med. Biol. 2018;1097:51&#x2013;68. doi: 10.1007/978-3-319-96445-4_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-96445-4_3</ArticleId><ArticleId IdType="pubmed">30315539</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgadillo L.F., Marsh G.A., Waugh R.E. Endothelial Glycocalyx Layer Properties and Its Ability to Limit Leukocyte Adhesion. Biophys. J. 2020;118:1564&#x2013;1575. doi: 10.1016/j.bpj.2020.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2020.02.010</ArticleId><ArticleId IdType="pmc">PMC7136287</ArticleId><ArticleId IdType="pubmed">32135082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Fang F., Gao W., Chen H., Wen J., Wen X., Chen J. The Structure and Function of the Glycocalyx and Its Connection With Blood-Brain Barrier. Front. Cell. Neurosci. 2021;15:739699. doi: 10.3389/fncel.2021.739699.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.739699</ArticleId><ArticleId IdType="pmc">PMC8529036</ArticleId><ArticleId IdType="pubmed">34690703</ArticleId></ArticleIdList></Reference><Reference><Citation>De Agostini A.I., Watkins S.C., Slayter H.S., Youssoufian H., Rosenberg R.D. Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: Antithrombin binding on cultured endothelial cells and perfused rat aorta. J. Cell. Biol. 1990;111:1293&#x2013;1304. doi: 10.1083/jcb.111.3.1293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.111.3.1293</ArticleId><ArticleId IdType="pmc">PMC2116297</ArticleId><ArticleId IdType="pubmed">2144002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z., Li L., Sch&#xe4;fer N., Huang Q., Maegele M., Gu Z. Endothelial glycocalyx in traumatic brain injury associated coagulopathy: Potential mechanisms and impact. J. Neuroinflammation. 2021;18:134. doi: 10.1186/s12974-021-02192-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02192-1</ArticleId><ArticleId IdType="pmc">PMC8204552</ArticleId><ArticleId IdType="pubmed">34126995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha D., Fu M., Qian Y. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19. Cells. 2022;11:1972. doi: 10.3390/cells11121972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11121972</ArticleId><ArticleId IdType="pmc">PMC9221624</ArticleId><ArticleId IdType="pubmed">35741101</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampoor S., Zahednasab H., Farahmand M., Mirzaei R., Zamani F., Tabibzadeh A., Bouzari B., Ajdarkosh H., Nikkhah M., Hashemi M.R., et al. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19) Int. Immunopharmacol. 2021;97:107684. doi: 10.1016/j.intimp.2021.107684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107684</ArticleId><ArticleId IdType="pmc">PMC8052477</ArticleId><ArticleId IdType="pubmed">33932696</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Li L., Chen Y., Ma J., Yang Y., Aodeng S., Cui Q., Wen K., Xiao M., Xie J., et al. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol. Med. 2021;27:151. doi: 10.1186/s10020-021-00412-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00412-1</ArticleId><ArticleId IdType="pmc">PMC8640509</ArticleId><ArticleId IdType="pubmed">34861818</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K., Okada H., Tomita H., Sumi K., Kakino Y., Yasuda R., Kitagawa Y., Fukuta T., Miyake T., Yoshida S., et al. Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury. Thromb. J. 2021;19:5. doi: 10.1186/s12959-021-00258-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-021-00258-x</ArticleId><ArticleId IdType="pmc">PMC7838859</ArticleId><ArticleId IdType="pubmed">33504351</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18:1094&#x2013;1099. doi: 10.1111/jth.14817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14817</ArticleId><ArticleId IdType="pmc">PMC9906401</ArticleId><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinaneh S., Khamaysi I., Karram T., Hamoud S. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy. Biosci. Rep. 2021;41:BSR20210290. doi: 10.1042/BSR20210290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210290</ArticleId><ArticleId IdType="pmc">PMC8255537</ArticleId><ArticleId IdType="pubmed">34132790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I., Pavlidis G., Katsimbri P., Lambadiari V., Parissis J., Andreadou I., Tsoumani M., Boumpas D., Kouretas D., Iliodromitis E. Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19. Food Chem. Toxicol. 2020;145:111694. doi: 10.1016/j.fct.2020.111694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2020.111694</ArticleId><ArticleId IdType="pmc">PMC7434461</ArticleId><ArticleId IdType="pubmed">32822775</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., Wu X., Novakovic V.A., Xie R., Shi J. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation. Front. Cell. Infect. Microbiol. 2022;12:861703. doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas M.Y., Javid M.A., Nazir M.M., Niaz N., Nisar M.F., Manzoor Z., Bhatti S., Hameed S., Khaliq M. Extracellular vesicles and exosome: Insight from physiological regulatory perspectives. J. Physiol. Biochem. 2022;78:573&#x2013;580. doi: 10.1007/s13105-022-00877-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13105-022-00877-6</ArticleId><ArticleId IdType="pubmed">35102530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S., Niida S., Azuma E., Yanagibashi T., Muramatsu M., Huang T.T., Sagara H., Higaki S., Ikutani M., Nagai Y., et al. Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci. Rep. 2015;5:8505. doi: 10.1038/srep08505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08505</ArticleId><ArticleId IdType="pmc">PMC4330530</ArticleId><ArticleId IdType="pubmed">25687367</ArticleId></ArticleIdList></Reference><Reference><Citation>Guervilly C., Bonifay A., Burtey S., Sabatier F., Cauchois R., Abdili E., Arnaud L., Lano G., Pietri L., Robert T., et al. Dissemination of extreme levels of extracellular vesicles: Tissue factor activity in patients with severe COVID-19. Blood Adv. 2021;5:628&#x2013;634. doi: 10.1182/bloodadvances.2020003308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003308</ArticleId><ArticleId IdType="pmc">PMC7846479</ArticleId><ArticleId IdType="pubmed">33560376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezine F., Guerin C.L., Philippe A., Gendron N., Soret L., Sanchez O., Mirault T., Diehl J., Chocron R., Boulanger C., et al. Increased Circulating CD62E+ Endothelial Extracellular Vesicles Predict Severity and in- Hospital Mortality of COVID-19 Patients. Stem Cell Rev. Rep. 2023;19:114&#x2013;119. doi: 10.1007/s12015-022-10446-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-022-10446-5</ArticleId><ArticleId IdType="pmc">PMC9387889</ArticleId><ArticleId IdType="pubmed">35982357</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. J. Am. Med. Assoc. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO&#x2014;World Health Organization  Post COVID-19 Condition (Long COVID)  [(accessed on 7 December 2022)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>WHO&#x2014;World Health Organization  Weekly Epidemiological Update on COVID-19.  [(accessed on 25 May 2023)].  Available online:  https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19.</Citation></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A., Lone N., Leavy O., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0. Erratum in Lancet Respir. Med. 2022, 10, e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J., Klaser K., Antonelli M., Canas L., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y. Erratum in Nat. Med. 2021, 27, 1116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., Ballouz T., Menges D., Hasler S., Adamo S., Raeber M., B&#xe4;chli E., Rudiger A., et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat. Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M., Alcaide P., Asselbergs F.W., Brundel B.J.J.M., Camici G.G., Martins P.D.C., Ferdinandy P., Fontana M., Girao H., Gnecchi M., et al. Long COVID and the cardiovascular system&#x2014;Elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc. Res. 2022;199:336&#x2013;356. doi: 10.1093/cvr/cvac115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinato D.J., Tabernero J., Bower M., Scotti L., Patel M., Colomba E., Dolly S., Loizidou A., Chester J., Mukherjee U., et al. OnCovid study group. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: Evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021;22:1669&#x2013;1680. doi: 10.1016/S1470-2045(21)00573-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(21)00573-8</ArticleId><ArticleId IdType="pmc">PMC8565932</ArticleId><ArticleId IdType="pubmed">34741822</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;19:373. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K., Kristoffersen D.T., Dell&#x2032;Isola A., Kiadaliri A., Turkiewicz A., Runhaar J., Bierma-Zeinstra S., Englund M., Magnus P., Kinge J., et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat. Commun. 2022;13:7363. doi: 10.1038/s41467-022-35240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N., Walker A., et al. Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Han E., Gy&#xf6;ngy&#xf6;si M. Long COVID&#x2014;Eine neue Herausforderung in der Medizin: Fokus auf Schwangerschaft und Stillzeit. J. Gyn&#xe4;kol. Endokrinol. 2023;33:7&#x2013;12. doi: 10.1007/s41974-023-00250-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41974-023-00250-5</ArticleId><ArticleId IdType="pmc">PMC9893966</ArticleId><ArticleId IdType="pubmed">36747883</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: A systematic review and meta-analysis. Int. J. Environ. Res. Public. Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos C.A.D., Fonseca Filho G.G., Alves M.M., Macedo E.Y.L., Pontes M.G.A., Paula A.P., Barreto C.T.R., Zeneide F.N., Nery A.F., Freitas R.A.O., et al. Maternal and Neonatal Outcomes Associated with Mild COVID-19 Infection in an Obstetric Cohort in Brazil. Am. J. Trop. Med. Hyg. 2022;107:1060. doi: 10.4269/ajtmh.22-0421.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.22-0421</ArticleId><ArticleId IdType="pmc">PMC9709018</ArticleId><ArticleId IdType="pubmed">36252801</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2. Erratum in Nat. Rev. Microbiol 2023, 21, 408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R.M., Gehlhausen J.R., Tabachnikova A., Tabacof L., Malik A., Kamath K., et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022 doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J., Burrell L., Kent S., Dore G., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.E., Goldberg S.A., Forman C., Munter S., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israleow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Halpert G., Schimke L.F., Ostrinski Y., Vojdani A., Baiocchi G.C., Freire P.P., Filgueiras I.S., Zyskind I., Lattin M.T., et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat. Commun. 2022;13:1220. doi: 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Briquez P.S., Rouhani S.J., Yu J., Pyzer A.R., Trujillo J., Dugan H.L., Stamper C.T., Changrob S., Sperling A.I., Wilson P.C., et al. Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Sci. Adv. 2022;8:3777. doi: 10.1126/sciadv.abn3777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abn3777</ArticleId><ArticleId IdType="pmc">PMC9544317</ArticleId><ArticleId IdType="pubmed">36206332</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotti F.M., Menchinelli G., Marchetti S., Posteraro B., Landi F., Sanguinetti M., Cattani P. Assessment of SARS-CoV-2 RNA Test Results Among Patients Who Recovered From COVID-19 With Prior Negative Results. JAMA Intern. Med. 2021;181:702. doi: 10.1001/jamainternmed.2020.7570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.7570</ArticleId><ArticleId IdType="pmc">PMC7662488</ArticleId><ArticleId IdType="pubmed">33180119</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymieux S., Uzbekov R., Rouill&#xe9; Y., Blanchard E., Hourioux C., Dubuisson J., Belouzard S., Roingeard P. Secretory Vesicles Are the Principal Means of SARS-CoV-2 Egress. Cells. 2021;10:2047. doi: 10.3390/cells10082047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082047</ArticleId><ArticleId IdType="pmc">PMC8393858</ArticleId><ArticleId IdType="pubmed">34440816</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosell A., Havervall S., von Meijenfeldt F., Hisada Y., Aguilera K., Grover S.P., Lisman T., Mackman N., Th&#xe5;lin C. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality&#x2014;Brief Report. Arterioscler. Thromb. Vasc. Biol. 2021;41:878&#x2013;882. doi: 10.1161/ATVBAHA.120.315547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315547</ArticleId><ArticleId IdType="pmc">PMC7837685</ArticleId><ArticleId IdType="pubmed">33267656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID endotheliopathy: Hypothesized mechanisms and potential therapeutic approaches. J. Clin. Investig. 2022;132:161167. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltzschig H.K., Carmeliet P. Hypoxia and Inflammation. N. Engl. J. Med. 2011;364:656&#x2013;665. doi: 10.1056/NEJMra0910283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0910283</ArticleId><ArticleId IdType="pmc">PMC3930928</ArticleId><ArticleId IdType="pubmed">21323543</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D., Guido G., Zerunian M., Polidori T., Lucertini E., Pucciarelli F., Polici M., Rucci C., Bracci B., Nicolai M., et al. Post-Acute Sequelae of COVID-19 Pneumonia: Six-month Chest CT Follow-up. Radiology. 2021;301:396&#x2013;405. doi: 10.1148/radiol.2021210834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210834</ArticleId><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cueto-Robledo G., Porres-Aguilar M., Puebla-Aldama D., Barrag&#xe1;n-Mart&#xed;nez M.D.P., Jurado-Hern&#xe1;ndez M.Y., Garc&#xed;a-C&#xe9;sar M., Torres Rojas M.B.T., Garc&#xed;a-Treminio C., Roldan-Valadez E. Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia. Curr. Probl. Cardiol. 2022;47:101004. doi: 10.1016/j.cpcardiol.2021.101004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2021.101004</ArticleId><ArticleId IdType="pmc">PMC8482545</ArticleId><ArticleId IdType="pubmed">34601005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kub&#xe1;nkov&#xe1; M., Hohberger B., Hoffmanns J., F&#xfc;rst J., Herrmann M., Guck J., Kr&#xe4;ter M. Physical phenotype of blood cells is altered in COVID-19. Biophys. J. 2021;120:2838&#x2013;2847. doi: 10.1016/j.bpj.2021.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021;9:e14726. doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Moasefi N., Fouladi M., Norooznezhad A.H., Yarani R., Rahmani A., Mansouri K. How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): Role of hypoxia-inducible factor 1&#x3b1;. Inflamm. Res. 2021;70:749&#x2013;752. doi: 10.1007/s00011-021-01469-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-021-01469-8</ArticleId><ArticleId IdType="pmc">PMC8233630</ArticleId><ArticleId IdType="pubmed">34173853</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundstr&#xf6;m A., Magnusson M., Mackman N., Thalin C., Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021;5:756&#x2013;759. doi: 10.1182/bloodadvances.2020003968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratchford S.M., Stickford J.L., Province V.M., Stute N., Augenreich M.A., Koontz L.K., Landry K.B., Stickford A. Vascular alterations among young adults with SARS-CoV-2. Am. J. Physiol. Heart Circ. Physiol. 2021;320:404&#x2013;410. doi: 10.1152/ajpheart.00897.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00897.2020</ArticleId><ArticleId IdType="pmc">PMC8083172</ArticleId><ArticleId IdType="pubmed">33306450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia-Renteria H., Travieso A., Sagir A., Mart&#xed;nez-G&#xf3;mez E., Carrascosa-Granada A., Toya T., N&#xfa;&#xf1;ez-Gil I., Estrada V., Lermani A., Escaned J. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int. J. Cardiol. 2021;345:153&#x2013;155. doi: 10.1016/j.ijcard.2021.10.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.10.140</ArticleId><ArticleId IdType="pmc">PMC8542397</ArticleId><ArticleId IdType="pubmed">34706286</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro L., Falsetti L., Zaccone V., Nesci A., Tosato M., Giupponi B., Savastano M.C., Moroncini G., Gasbarrini A., Landi F., et al. Impaired Endothelial Function in Convalescent Phase of COVID-19: A 3 Month Follow Up Observational Prospective Study. J. Clin. Med. 2022;11:1774. doi: 10.3390/jcm11071774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071774</ArticleId><ArticleId IdType="pmc">PMC8999944</ArticleId><ArticleId IdType="pubmed">35407382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh F.W., Fong S.W., Young B.E., Wu K.X., Siau A., Krishnan S., Chan Y.H., Carissimo G., Teo L.l., Gao F., et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. eLife. 2021;10:e64909. doi: 10.7554/eLife.64909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin J.F., Almansa R., Torres A., Gonz&#xe1;lez-Rivera M., Kelvin D.J. COVID-19 as a cardiovascular disease: The potential role of chronic endothelial dysfunction. Cardiovasc. Res. 2020;116:132&#x2013;133. doi: 10.1093/cvr/cvaa140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa140</ArticleId><ArticleId IdType="pmc">PMC7314234</ArticleId><ArticleId IdType="pubmed">32420587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., Ma K., Xu D., Yu H., Wang H., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;368:1091. doi: 10.1136/bmj.m1091. Erratum in BMJ 2020, 368, m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoliquido A., Porfidia A., Nesci A., De Matteis G., Marrone G., Porceddu E., Camm&#xe0; G., Giarretta I., Fantoni M., Landi F., et al. Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis. J. Thromb. Haemost. 2020;18:2358&#x2013;2363. doi: 10.1111/jth.14992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14992</ArticleId><ArticleId IdType="pmc">PMC7361278</ArticleId><ArticleId IdType="pubmed">32633068</ArticleId></ArticleIdList></Reference><Reference><Citation>Llitjos J., Leclerc M., Chochois C., Monsallier J., Ramakers M., Auvray M., Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J. Thromb. Haemost. 2020;18:1743&#x2013;1746. doi: 10.1111/jth.14869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14869</ArticleId><ArticleId IdType="pmc">PMC7264774</ArticleId><ArticleId IdType="pubmed">32320517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021;75:e13746. doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., Kumar K., Vimalesvaran K., Thornton G., Patel R., Chacko L., Brown J.T., Coyle C., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021;42:1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19. JAMA Netw. Open. 2021;4:2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Arnold A.C., Barboi A., Claydon V.E., Limberg J.K., Lucci V.E.M., Numan M., Peltier A., Snapper H., Vernino S. Long-COVID postural tachycardia syndrome: An American Autonomic Society statement. Clin. Auton. Res. 2021;31:365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Hsu C.K., Yen M.Y., Lee P.I., Ko W.C., Hsueh P.R. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 2023;56:1&#x2013;9. doi: 10.1016/j.jmii.2022.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pmc">PMC9576029</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T., Yan M.Z., Li X., Lau E.H.Y. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: A systematic review and meta-analysis. Infection. 2022;50:1067&#x2013;1109. doi: 10.1007/s15010-022-01862-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01862-3</ArticleId><ArticleId IdType="pmc">PMC9244338</ArticleId><ArticleId IdType="pubmed">35750943</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo F., Wormanns D., Groh&#xe9; C. COVID-19 aus Sicht der Pneumologie&#x2014;Langzeitfolgen und Implikationen f&#xfc;r die pneumologische Nachsorge. [COVID-19: A Pneumological Point of View&#x2014;Long-Term Sequelae of COVID-19&#x2014;Implications For Follow-up In Respiratory Medicine] Dtsch. Med. Wochenschr. 2020;145:1086&#x2013;1092. doi: 10.1055/a-1164-4040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1164-4040</ArticleId><ArticleId IdType="pubmed">32731284</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.O., Brutsche M., Clarenbach C., Garzoni C., Geiser T.K., Lenoir A., Mancinetti M., et al. Pulmonary function and radiological features 4 months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study. Eur. Respir. J. 2021;57:2003690. doi: 10.1183/13993003.03690-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A., L&#xf3;pez-Romero S., Figueroa-Hurtado E., Pou-Aguilar Y.N., Wong A.W., Milne K.M., Ryerson C.J., Guenette J.A. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir. Physiol. Neurobiol. 2021;288:103644. doi: 10.1016/j.resp.2021.103644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X., Jian W., Su Z., Chen M., Peng H., Peng P., Lei C., Chen R., Zhong N., Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020;55:2001217. doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W., Chen S., Zhang Y., Dong F., Zhang Z., Hu B., Zhu Z., Li F., Wang X., Wang Y., et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur. Respir. J. 2021;58:2003677. doi: 10.1183/13993003.03677-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03677-2020</ArticleId><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccone V., Falsetti L., Nitti C., Gentili T., Marchetti A., Pier Santelli M.N., Sampaolesi M., Riccomi F., Raponi A., Salvi A. The Prognostic Role of Procalcitonin in Critically Ill Patients Admitted in a Medical Stepdown Unit: A Retrospective Cohort Study. Sci. Rep. 2020;10:4531. doi: 10.1038/s41598-020-61457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-61457-6</ArticleId><ArticleId IdType="pmc">PMC7066188</ArticleId><ArticleId IdType="pubmed">32161314</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen J.L., Yang W., Ito K., Matte T.D., Shaman J., Kinney P.L. Seasonal Influenza Infections and Cardiovascular Disease Mortality. JAMA Cardiol. 2016;1:274. doi: 10.1001/jamacardio.2016.0433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2016.0433</ArticleId><ArticleId IdType="pmc">PMC5158013</ArticleId><ArticleId IdType="pubmed">27438105</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong T.Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: Acute and long-term implications. Eur. Heart J. 2020;41:1798&#x2013;1800. doi: 10.1093/eurheartj/ehaa231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa231</ArticleId><ArticleId IdType="pmc">PMC7454513</ArticleId><ArticleId IdType="pubmed">32186331</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majidi S., Kellner C.P., Shoirah H., Singh I.P., De Leacy R.A., Shigematsu T., Ladner T.R., Yaeger K.A., et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N. Engl. J. Med. 2020;382:e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud E., Dauerman H.L., Welt F.G.P., Messenger J.C., Rao S.V., Grines C., Mattu A., Kirtane A.J., Jauhar R., Meraj P., et al. Management of acute myocardial infarction during the COVID-19 pandemic. Catheter. Cardiovasc. Interv. 2020;96:336&#x2013;345. doi: 10.1002/ccd.28946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.28946</ArticleId><ArticleId IdType="pubmed">32311816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.W., Belin de Chantem&#xe8;le E.J., Weintraub N.L. Perivascular Adipocytes in Vascular Disease. Arterioscler. Thromb. Vasc. Biol. 2019;39:2220&#x2013;2227. doi: 10.1161/ATVBAHA.119.312304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.119.312304</ArticleId><ArticleId IdType="pmc">PMC6812617</ArticleId><ArticleId IdType="pubmed">31510794</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Grabowski P., Heidecke H., Bauer S., Hanitsch L.G., Wittke K., Maisel C., Reinke P., Volk H., Fluge &#xd8;., et al. Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav. Immun. 2016;52:32&#x2013;39. doi: 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundstr&#xf6;m A., Rudberg A.S., Magnusson M., Mackman N., Thalin C., Lisman T. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res. Pract. Thromb. Haemost. 2020;5:132&#x2013;141. doi: 10.1002/rth2.12462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12462</ArticleId><ArticleId IdType="pmc">PMC7845083</ArticleId><ArticleId IdType="pubmed">33537537</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox S.E., Akmatbekov A., Harbert J.L., Li G., Quincy Brown J., Vander Heide R.S. Pulmonary and cardiac pathology in African American patients with COVID-19: An autopsy series from New Orleans. Lancet Respir. Med. 2020;8:681&#x2013;686. doi: 10.1016/S2213-2600(20)30243-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30243-5</ArticleId><ArticleId IdType="pmc">PMC7255143</ArticleId><ArticleId IdType="pubmed">32473124</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D., Sperhake J.P., L&#xfc;tgehetmann M., Steurer S., Edler C., Heinemann A., Heinrich A., Mushumba H., Kniep I., Schr&#xf6;der A.S., et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann. Intern. Med. 2020;173:268&#x2013;277. doi: 10.7326/M20-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurence J., Nuovo G., Racine-Brzostek S.E., Seshadri M., Elhadad S., Crowson A.N., Mulvey J.J., Harp J., Ahamed J., Magro C. Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage. Am. J Pathol. 2022;192:1282&#x2013;1294. doi: 10.1016/j.ajpath.2022.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2022.05.006</ArticleId><ArticleId IdType="pmc">PMC9144849</ArticleId><ArticleId IdType="pubmed">35640675</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf3;jcik K., Bazan-Socha S., Celejewska-W&#xf3;jcik N., G&#xf3;rka K., Licho&#x142;ai S., Polok K., Stachura T., Zar&#x119;ba L., Dziedzic R., Gradzikiewicz A., et al. Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 patients. Thromb Res. 2023;223:80&#x2013;86. doi: 10.1016/j.thromres.2023.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2023.01.016</ArticleId><ArticleId IdType="pmc">PMC9872442</ArticleId><ArticleId IdType="pubmed">36709678</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., Bergin C., O&#x2032;Farrelly C., Conlon N., Bourke N.M., et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb. Haemost. 2021;19:1064&#x2013;1070. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D., Allen S.L., Tsang J., Flint S., Pinhasov T., Williams S., Tan G., Thakur R., Leung C., Snyder M., et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: The CORE-19 registry. Blood. 2021;137:2838&#x2013;2847. doi: 10.1182/blood.2020010529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020010529</ArticleId><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelen M.M., Vandenbriele C., Balthazar T., Claeys E., Gunst J., Guler I., Jacquemin M., Janssens S., Lorent N., Liesenborghs L., et al. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization. Semin. Thromb. Hemost. 2021;47:362&#x2013;371. doi: 10.1055/s-0041-1727284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1727284</ArticleId><ArticleId IdType="pubmed">33893631</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R., Bogue T., Koshy A., Bindal P., Merrill M., Aird W.C., Bauer K.A., Zwicker J.I. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136:1342&#x2013;1346. doi: 10.1182/blood.2020007938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007938</ArticleId><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Taccone F.S., Gevenois P.A., Peluso L., Pletchette Z., Lheureux O., Brasseur A., Garufi A., Talamonti M., Motte S., Nobile L., et al. Higher Intensity Thromboprophylaxis Regimens and Pulmonary Embolism in Critically Ill Coronavirus Disease 2019 Patients. Crit. Care Med. 2020;48:e1087&#x2013;e1090. doi: 10.1097/CCM.0000000000004548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004548</ArticleId><ArticleId IdType="pmc">PMC7437413</ArticleId><ArticleId IdType="pubmed">32769623</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan Y., Yilmaz G., Dogan D., Hasirci M., Cetindogan H., Ocal N., Savasci U., Fidan G., Tasci C. The effectiveness of early anticoagulant treatment in Covid-19 patients. Phlebology. 2021;36:384&#x2013;391. doi: 10.1177/0268355520975595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0268355520975595</ArticleId><ArticleId IdType="pubmed">33243082</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentsch C.T., Beckman J.A., Tomlinson L., Gellad W.F., Alcorn C., Kidwai-Khan F., Skanderson M., Brittani E., King J.T., Jr., Ho Y.L., et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: Cohort study. BMJ. 2021;372:n311. doi: 10.1136/bmj.n311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n311</ArticleId><ArticleId IdType="pmc">PMC7876672</ArticleId><ArticleId IdType="pubmed">33574135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E., Barile Agati L., Calderaro D., Aguiar V.C.R., Spyropoulos A.C., de Oliveira C.C.C., Dos Santos J.L., Volpiani G.G., Sobreira M.L., Joviliano E.E., et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): An open-label, multicentre, randomised, controlled trial. Lancet. 2022;399:50&#x2013;59. doi: 10.1016/S0140-6736(21)02392-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02392-8</ArticleId><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores L.K., Tritschler T., Brosnahan S., Carrier M., Collen J.F., Doerschug K., Holley A.B., Jimenez D., Le Gal G., Rali P., et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019. Chest. 2020;158:1143&#x2013;1163. doi: 10.1016/j.chest.2020.05.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.05.559</ArticleId><ArticleId IdType="pmc">PMC7265858</ArticleId><ArticleId IdType="pubmed">32502594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A., Tseng E.K., Nieuwlaat R., Angchaisuksiri P., Blair C., Dane K., Davila J., DeSancho M.T., Diuguid D., Griffin D.O., et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Adv. 2022;6:664&#x2013;671. doi: 10.1182/bloodadvances.2021005945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021005945</ArticleId><ArticleId IdType="pmc">PMC8566097</ArticleId><ArticleId IdType="pubmed">34727173</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B., Madhavan M.V., Jimenez D., Chuich T., Dreyfus I., Driggin E., Der Nigoghossian C., Ageno W., Madjid M., Guo Y., et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up. J. Am. Coll. Cardiol. 2020;75:2950&#x2013;2973. doi: 10.1016/j.jacc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos A.C., Levy J.H., Ageno W., Connors J.M., Hunt B.J., Iba T., Levi M., Samama C.M., Thachil J., Giannis D., et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020;18:1859&#x2013;1865. doi: 10.1111/jth.14929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14929</ArticleId><ArticleId IdType="pmc">PMC7283841</ArticleId><ArticleId IdType="pubmed">32459046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.W., Yusof Khan A.H.K., Ching S.M., Chia P.K., Loh W.C., Abdul Rashid A.M., Baharin J., Inche Mat L.N., Wan Sulaiman W.A., Devaraj N.K., et al. Stroke and Novel Coronavirus Infection in Humans: A Systematic Review and Meta-Analysis. Front. Neurol. 2020;11:579070. doi: 10.3389/fneur.2020.579070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.579070</ArticleId><ArticleId IdType="pmc">PMC7573135</ArticleId><ArticleId IdType="pubmed">33123082</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;Mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648. Erratum in BMJ. 2021, 374, n1944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewek J., Jatczak-Pawlik I., Maciejewski M., Jankowski P., Banach M. COVID-19 and cardiovascular complications&#x2014;The preliminary results of the LATE-COVID study. Arch. Med. Sci. 2021;17:818&#x2013;822. doi: 10.5114/aoms/134211.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms/134211</ArticleId><ArticleId IdType="pmc">PMC8130484</ArticleId><ArticleId IdType="pubmed">34025853</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., Binda F., Zuglian G., Imeri G., Conti C., Biffi A.M., Spada M.S., Bondi E., et al. Surviving COVID-19 in Bergamo province: A post-acute outpatient re-evaluation. Epidemiol. Infect. 2021;149:e32. doi: 10.1017/S0950268821000145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Boehm A., Sahanic S., Pizzini A., Aichner M., Sonnweber B., Kurz K., Koppelst&#xe4;tter S., Haschka D., Petzer V., et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients&#x2032; performance: A prospective observational cohort study. Respir. Res. 2020;21:276. doi: 10.1186/s12931-020-01546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01546-2</ArticleId><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>